Skip to content
  • Sunday, 26 July 2026
  • 4:35 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Copper drug clears toxic Alzheimer’s proteins and restores memory
Neuroscience & Brain Research

Copper drug clears toxic Alzheimer’s proteins and restores memory

Rifan Muazin Jun 16, 2026 0

In a significant advancement for neuropharmacology, researchers at Monash University have identified a copper-based drug candidate that demonstrates a dual-action…

Read More
Neuroscience & Brain Research

Caffeine Restores Social Memory Impaired by Sleep Deprivation According to New Research from NUS Medicine

Rifan Muazin May 30, 2026 0

Researchers at the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) have identified a…

Read More
Long-Term Caffeinated Coffee and Tea Consumption Linked to Reduced Dementia Risk and Better Cognitive Preservation in Large Scale Prospective StudyNew Theoretical Model Suggests Collapsing Stars May Form Gravastars Containing Miniature Universes Rather Than Black HolesGenome’s Early Architectural Masterpiece Revealed: A Paradigm Shift in Developmental BiologyTWiV 1289: Building a better hepatitis B trap
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ